Journals / Medicine Science / 2016 / Cilt: 5 - Sayı: 1

Screening the Effect of Metformin on Serum Vitamin B12 and Blood Homocysteine Levels in Patients with Type 2 Diabetes Mellitus

Pages
46–56
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vitamin B12 deficiency was found to be associated with metformin use in T2DM patients with significant correlation with diabetic peripheral neuropathy and hyper-homocysteinemia, whereas vitamin B12 supplementation with metformin could prevent those effects

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin B12 deficiency is a side effect of metformin use in patientswith type 2 diabetes mellitus (T2DM) and associated with increase in plasma homocysteine levels.The aim of present work was to screen vitamin B12 and homocysteine levels in patients with T2DM on metformin therapy.
📊
Key Findings & Data:Patients with T2DM collected from Fayoum University hospital outpatient clinics were screened and divided into three groups.
💡
Conclusion & Impact:Vitamin B12 deficiency was found to be associated with metformin use in T2DM patients with significant correlation with diabetic peripheral neuropathy and hyper-homocysteinemia, whereas vitamin B12 supplementation with metformin could prevent those effects
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vitamin B12 deficiency is a side effect of metformin use in patientswith type 2 diabetes mellitus (T2DM) and associated with increase in plasma homocysteine levels.The aim of present work was to screen vitamin B12 and homocysteine levels in patients with T2DM on metformin therapy. Patients with T2DM collected from Fayoum University hospital outpatient clinics were screened and divided into three groups. Group 1 was thirty patients on metformin therapy for more than one year without vitamin B12 supplementation; group 2 was thirty patients on metformin therapy for more than one year on vitamin B12 supplementation and group 3 was patients not receiving metformin therapy (control group). All patients were subjected to complete history taking, including peripheral neuropathy and laboratory investigations. The mean±SD serum vitamin B12 level was significantly higher in the metformin and vitamin B12 supplementation users compared to metforminonly and nonmetformin users (p<0.001), 629.9±249, 216±109 and 354.6±177.6 ng/L, respectively. Homocysteine levels were similar in the three groups. There was a significant correlation between metformin dose and vitamin B12 levels (P<0.05), also between vitamin B12 deficiency and hyperhomocysteinemia (P<0.01, r=-0.45). There was significant relation between homocysteine and macrovascular complications (r= 0.33, P<0.01) and between vitamin B12and peripheral neuropathy (P<0.01, r=-0.303). Vitamin B12 deficiency was found to be associated with metformin use in T2DM patients with significant correlation with diabetic peripheral neuropathy and hyper-homocysteinemia, whereas vitamin B12 supplementation with metformin could prevent those effects

🔖

Cite This Article

OSAMA, H., HUSSEİN, H. A. E., ABDELRAHİM, M. E., SALEM, H. F. (2016). Screening the Effect of Metformin on Serum Vitamin B12 and Blood Homocysteine Levels in Patients with Type 2 Diabetes Mellitus. Medicine Science, Cilt: 5 - Sayı: 1, 46–56. https://ajindex.com/articles/277517

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zhang Y, Xie Y, Meng D, Zhang H, Chen H, Liu E. Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes. Diabetol Metab Syndr. 2014;6(1):37
  2. Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. “Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy”. Diabetes Obes Metab. 2006;8(2):156-63
  3. Prato S, Lebovitz H. Pharmacological Treatment of Type 2 Diabetes: Advantages and Dilemmas. Transl Endocrinol Metab. 2014;(3)2:27
  4. Derosa G1, Mugellini A, Ciccarelli L, Crescenzi G, Fogari R. Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin. Diabetes Res Clin Pract. 2003;60(3):161-9
  5. Wile DJ, Toth C. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010;33(1):156-61
  6. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Topolski R. The Prevalence of Vitamin B12 Deficiency in Patients with Type 2 Diabetes: A Cross-Sectional Study. J Am Board Fam Med. 2009;22(5):528-34
  7. Hermann L, Nilsson B, Wettre S. Vitamin B12 status of patients treated with metformin: a cross-sectional cohort study. Br J Diabetes Vasc Dis. 2004;4(6):401-406
  8. Nervo M, Lubini A, Raimundo F. Vitamin B12 in metformin-treated diabetic patients: a cross-sectional study in Brazil. Rev Assoc Med Bras. 2011;57(1):46-9
  9. Liu K, Dai L, Jean W. Metformin-related vitamin B12 deficiency. Age Ageing. 2006;35(2):200-1
  10. Bell D. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J. 2010;103(3):265-7
  11. Kumthekar A, Gidwani H, Kumthekar A. Metformin Associated B12 Deficiency. J Assoc Physicians India. 2012;60:58-60
  12. Reinstatler L, Qi Y, Williamson R, Garn J, Oakley-Jr G. Association of Biochemical B12 Deficiency with Metformin Therapy and Vitamin B12 Supplements. The National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2012;35(2):327-33
  13. Qureshi S, Ainsworth A, Winocour P. Metformin therapy and assessment for vitamin B12 deficiency: is it necessary? Pract Diabetes. 2011;28(7):302-4
  14. Chan Chee Wun Joyce, Chan Hoi Yan Florence, Wong Ho Nam Howard, Yeung Chun Yip. Characteristics of Vitamin B12 Deficiency in Adult Chinese Patients with Type 2 Diabetes and the